Particle Therapy Market

Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023

Report Code: MD 6747 Nov, 2018, by marketsandmarkets.com

[138 Pages Report] The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

The particle therapy market comprises several stakeholders such as particle therapy product manufacturers, suppliers and distributors, healthcare service providers, and research institutes. The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is the breakdown of primary respondents:

Particle Therapy Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the particle therapy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the particle therapy industry.

Report Objectives

  • To define, describe, and forecast the global particle therapy market on the basis of type, product & service, cancer type, system, application, and region
  • To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global particle therapy market
  • To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global particle therapy market
  • To analyze the opportunities in the global particle therapy market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
  • To profile the key players in the global particle therapy market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, agreements, partnerships, collaborations, and acquisitions in the global particle therapy market

Scope of the Report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Value (USD)

Segments covered

Type, product & service, system, cancer type, application, and region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW

Companies covered

Major 10 players covered, including Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Mevion Medical Systems, Inc. (US), and Sumitomo Heavy Industries, Ltd. (Japan).

This research report categorizes the particle therapy market based on type, product & service, cancer type, system, application, and region.

Particle Therapy Market, by Type

  • Proton Therapy
  • Heavy Ion Therapy 

Particle Therapy Market, by Product & Service

  • Products
  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons
  • Services

Particle Therapy Market, by System

  • Multi-room Systems
  • Single-room Systems

Particle Therapy Market, by Cancer Type

  • Pediatric Cancer
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Other Cancers (Lymphoma, Sarcoma, Spine Cancer, Pancreatic Cancer, Brain Cancer, Secondary/Reoccurring Cancer, and Gastrointestinal Cancer, Among Others)

Particle Therapy Market, by Application

  • Treatment Applications
  • Research Applications

Particle Therapy Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global particle therapy market report:

Product Analysis

  • Product matrix which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

The particle therapy market is projected to grow from an estimated USD 865 million in 2018 to USD 1,349 million by 2023, at a CAGR of 9.3% during the forecast period. Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.

Particle Therapy Market

By product, the synchrotron segment is expected to grow at the highest rate during the forecast period

Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen. The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.

By type, proton therapy is expected to be the largest contributor to the particle therapy market

The large share of the proton therapy segment can be attributed to factors such as the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays. Other factors such as the increasing research activities in the field of radiation oncology using proton therapy systems, rising number of proton therapy centers, and longer equipment lifespan of proton therapy (30 years or more) in comparison to photon therapy (10 years) are expected to support the growth of this market in the coming years.

By application, treatment applications are expected to be the largest contributor to the particle therapy market

The introduction of small footprint single-room particle therapy centers is further promoting the adoption of proton therapy for the treatment of cancer in small-scale hospitals. Factors driving the growth of the treatment applications segment include the growing number of cancer patients globally, increasing government initiatives (aimed at equipping or upgrading hospitals with newer and advanced radiotherapy systems), and the increasing availability of funding for the adoption of advanced cancer treatment technologies.

Particle Therapy Market

Asia Pacific is expected to hold a significant share in the particle therapy market during the forecast period

The Asia Pacific is one of the major revenue generating regions in the particle therapy market. China and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, the increasing geriatric population, growing incidence of cancer, and rising acceptance of particle therapy procedures and devices are also driving the growth of this regional market.

Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), and Hitachi, Ltd. (Japan) are the major players operating in the particle therapy market. Other players in this market include Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy Plc. (UK), and Danfysik A/S (Denmark).

Hitachi, Ltd. (Japan) is one of the leading players operating in the particle therapy market. Hitachi's proton beam therapy products have been used to treat more than 16,000 patients worldwide, and the company continues to perform joint research with advanced cancer hospitals in the US. Also, the company focuses on agreements with leading research organizations to strengthen its product development capabilities in the field of particle therapy.

Recent Developments

  • In 2017, Mitsubishi Electric signed an agreement to transfer its particle therapy systems business to Hitachi and integrate into one entity. This helped Hitachi to improve its position in the proton therapy market.
  • In 2017, Royal Philips (US) and Proton Partners International (UK) collaborated with IBA (Belgium) to build the first compact proton therapy system in the Middle East.
  • In 2016, Provision Asia (HK) Limited and Shenzhen Hairong International Medical Development Co., Ltd. entered into a joint venture to form Provision China. This company will be an exclusive distributor of the ProNova SC360 Proton Therapy System.

Key questions addressed by the report:

  • What are the growth opportunities related to the adoption of heavy ion therapy across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of particle therapy. Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the various cancer types wherein particle therapy finds a high adoption rate?
  • What are the new trends and advancements in the particle therapy market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Volume-Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Limitations and Assumptions
           2.4.1 Limitations
           2.4.2 Assumptions

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 36)
    4.1 Particle Therapy: Market Overview
    4.2 Regional Analysis: Particle Therapy Market, By Product & Service
    4.3 Particle Therapy Market Size, By Type
    4.4 Particle Therapy Market Size, By Cancer Type
    4.5 Regional Analysis: Particle Therapy Market, By Application
    4.6 Particle Therapy Market, By Region

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Advantages Offered By Particle Therapy Over Photon Therapy
                    5.2.1.2 Growing Global Prevalence of Cancer
                    5.2.1.3 Growing Adoption of Particle Therapy in Clinical Trials
                    5.2.1.4 Increasing Number of Particle Therapy Centers Worldwide
           5.2.2 Restraints
                    5.2.2.1 Infrastructural Challenges in Healthcare Facilities
                    5.2.2.2 Affordability and Accessibility of Treatments
                    5.2.2.3 Unfavorable Reimbursement Policies and Limited Insurance Coverage for Particle Therapy
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets
           5.2.4 Industry Trends
                    5.2.4.1 Growing Adoption of Pencil-Beam Scanning

6 Particle Therapy Market, By Type (Page No. - 48)
    6.1 Introduction
    6.2 Proton Therapy
           6.2.1 Proton Therapy is Increasingly Being Adopted as A Primary Treatment Mode for Various Cancer Types
    6.3 Heavy Ion Therapy
           6.3.1 The Use of Heavy Ion Therapy is Still in the Experimental Phase Across Many Regions

7 Particle Therapy Market, By Product & Service (Page No. - 52)
    7.1 Introduction
    7.2 Products
           7.2.1 Cyclotrons
                    7.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
           7.2.2 Synchrotrons
                    7.2.2.1 Increasing Investments Into the Development of Synchrotron Facilities are Contributing to Market Growth
           7.2.3 Synchrocyclotrons
                    7.2.3.1 The High Space Requirements of Synchrocyclotrons are Limiting Their Widespread Adoption
    7.3 Services

8 Particle Therapy Market, By System (Page No. - 60)
    8.1 Introduction
    8.2 Multi-Room Systems
           8.2.1 Lower Shielding Requirements and Faster Beam-Switching Capabilities of Multi-Room Systems are Increasing Interest Among End Users
    8.3 Single-Room Systems
           8.3.1 Compact Structure and Reduced Capital Costs are Leading to High Growth of Single-Room Systems

9 Particle Therapy Market, By Cancer Type (Page No. - 64)
    9.1 Introduction
           9.1.1 Pediatric Cancer
                    9.1.1.1 Better Control of Radiation With Particle Therapy Makes It the Most Suitable Treatment Mode for Pediatric Cancer
           9.1.2 Prostate Cancer
                    9.1.2.1 Particle Therapy Offers A Minimally Invasive Alternative With Increased Accuracy for Prostate Cancer Treatment
           9.1.3 Lung Cancer
                    9.1.3.1 Rising Number of Clinical Trials to Optimize the Use of Particle Therapy for Lung Cancer is Driving the Growth of the Market
           9.1.4 Breast Cancer
                    9.1.4.1 Limited Radiation Exposure With Reduced Side-Effects is Increasing the Adoption of Particle Therapy for Breast Cancer
           9.1.5 Head and Neck Cancer
                    9.1.5.1 The Use of Pencil-Beam Scanning for Proton Therapy Supports Market Growth for This Segment
           9.1.6 Other Cancers

10 Particle Therapy Market, By Application (Page No. - 69)
     10.1 Introduction
     10.2 Treatment Applications
             10.2.1 Introduction of Small Footprint Single-Room Particle Therapy Centres is Promoting the Adoption of Particle Therapy for Cancer Treatment
     10.3 Research Applications
             10.3.1 Increasing Availability of Funding for Particle Therapy-Related Research Projects is Providing Growth Opportunities in Research Applications

11 Particle Therapy Market, By Region (Page No. - 74)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                       11.2.1.1 Growing Number of Particle Therapy Centers in the US to Drive Market Growth
             11.2.2 Canada
                       11.2.2.1 Canadian Government Undertaking Initiatives to Include Particle Therapy as A Treatment Method
     11.3 Europe
             11.3.1 France
                       11.3.1.1 Increasing Healthcare Expenditure in France is Supporting the Adoption of Particle Therapy Products
             11.3.2 Germany
                       11.3.2.1 Increasing Research in the Field of Proton & Heavy Ion Therapy to Drive the Growth of the Particle Therapy Market in Germany
             11.3.3 UK
                       11.3.3.1 Cyclotrons Segment Dominated the Particle Therapy Market  in the UK
             11.3.4 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
                       11.4.1.1 Japan is the Largest User of Heavy Ion Therapy for the Treatment of Various Types of Cancers
             11.4.2 China
                       11.4.2.1 Growing Interest of Major Market Players to Increase Their Presence in China Will Drive the Growth of the Particle Therapy Market in the Country
             11.4.3 India
                       11.4.3.1 Leading Product Manufacturers are Entering the Indian Particle Therapy Market Owing to the High Growth Opportunities in the Country
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World
             11.5.1 Inadequate Healthcare Infrastructure is Restraining the Widespread Adoption of Particle Therapy in the Region

12 Competitive Landscape (Page No. - 108)
     12.1 Introduction
     12.2 Market Share Analysis
     12.3 Competitive Scenario
             12.3.1 Product Launches and Approvals
             12.3.2 Acquisitions
             12.3.3 Expansions
             12.3.4 Agreements and Collaborations

13 Company Profiles: Particle Therapy Market (Page No. - 112)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     13.1 Varian Medical Systems, Inc.
     13.2 Ion Beam Applications Sa (IBA)
     13.3 Mevion Medical Systems, Inc.
     13.4 Provision Healthcare, LLC
     13.5 Sumitomo Heavy Industries, Ltd.
     13.6 Hitachi, Ltd.
     13.7 Optivus Proton Therapy, Inc.
     13.8 Protom International, Inc.
     13.9 Advanced Oncotherapy PLC.
     13.10 Danfysik A/S

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 131)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Available Customizations
     14.4 Related Reports
     14.5 Author Details


List of Tables (80 Tables)

Table 1 Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 2 Proton Therapy Market, By Region, 2016–2023 (USD Million)
Table 3 Heavy Ion Therapy Market, By Region, 2016–2023 (USD Million)
Table 4 Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 5 Particle Therapy Product & Service Market, By Region, 2016–2023 (USD Million)
Table 6 Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 7 Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 8 Particle Therapy Products Market, By Region, 2016–2023 (USD Million)
Table 9 Cyclotrons Market, By Region, 2016–2023 (USD Million)
Table 10 Cyclotrons Market, By Region, 2016–2023 (Units)
Table 11 Synchrotrons Market, By Region, 2016–2023 (USD Million)
Table 12 Synchrotrons Market, By Region, 2016–2023 (Units)
Table 13 Synchrocyclotrons Market, By Region, 2016–2023 (USD Million)
Table 14 Synchrocyclotrons Market, By Region, 2016–2023 (Units)
Table 15 Particle Therapy Services Market, By Region, 2016–2023 (USD Million)
Table 16 Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 17 Particle Therapy Market for Multi-Room Systems, By Region, 2016–2023 (USD Million)
Table 18 Particle Therapy Market for Single-Room Systems, By Region, 2016–2023 (USD Million)
Table 19 Particle Therapy Market, By Cancer Type, 2016–2023 (USD Million)
Table 20 Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 21 Particle Therapy Market for Treatment Applications, By Region, 2016–2023 (USD Million)
Table 22 Particle Therapy Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 23 Particle Therapy Market, By Region, 2016–2023 (USD Million)
Table 24 North America: Particle Therapy Market, By Country, 2016–2018 (USD Million)
Table 25 North America: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 26 North America: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 27 North America: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 28 North America: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 29 North America: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 30 North America: Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 31 US: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 32 US: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 33 US: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 34 Canada: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 35 Canada: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 36 Canada: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 37 Europe: Particle Therapy Market, By Country, 2016–2018 (USD Million)
Table 38 Europe: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 39 Europe: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 40 Europe: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 41 Europe: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 42 Europe: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 43 Europe: Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 44 France: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 45 France: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 46 France: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 47 Germany: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 48 Germany: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 49 Germany: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 50 UK: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 51 UK: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 52 UK: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 53 RoE: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 54 RoE: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 55 RoE: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 56 Asia Pacific: Particle Therapy Market, By Country, 2016–2018 (USD Million)
Table 57 Asia Pacific: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 58 Asia Pacific: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 59 Asia Pacific: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 60 Asia Pacific: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 61 Asia Pacific: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 62 Asia Pacific: Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 63 Japan: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 64 Japan: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 65 Japan: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 66 China: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 67 China: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 68 China: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 69 India: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 70 India: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 71 India: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 72 RoApac: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 73 RoApac: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 74 RoApac: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 75 RoW: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 76 RoW: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 77 RoW: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 78 RoW: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 79 RoW: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 80 RoW: Particle Therapy Market, By Application, 2016–2023 (USD Million)
 
 
List of Figures (36 Figures)
 
Figure 1 Particle Therapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Particle Therapy Market
Figure 4 Top-Down Approach Market Size Estimation: Particle Therapy Product Market
Figure 5 Top-Down Approach Market Size Estimation: Particle Therapy Services Market
Figure 6 Data Triangulation Methodology
Figure 7 Particle Therapy Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Particle Therapy Products Market Share, By Type, 2018 vs 2023
Figure 9 Regional Analysis: Particle Therapy Market, By System, 2018 (USD Million)
Figure 10 Particle Therapy Market Share, By Cancer Type, 2018 vs 2023
Figure 11 Particle Therapy Market, By Application, 2018 vs 2023 (USD Million)
Figure 12 Particle Therapy Market: Geographical Snapshot
Figure 13 Increasing Cancer Prevalence is Driving Growth of the Particle Therapy Market
Figure 14 Services Segment to Witness High Growth in the APAC Market During the Forecast Period
Figure 15 Proton Therapy Will Dominate the Market During the Forecast Period (2018–2023)
Figure 16 Pediatric Cancer Segment Will Grow at the Fastest Rate in the Market During the Forecast Period
Figure 17 Treatment Application Segment is Estimated to Hold the Largest Share of the Market Globally in 2018
Figure 18 Asia Pacific to Witness Fastest Growth During the Forecast Period (2018–2023)
Figure 19 Growing Incidence of Cancer, By Region, 2012–2020 (Thousands)
Figure 20 Proton Therapy Segment to Dominate the Particle Therapy Market During the Forecast Period
Figure 21 Cyclotrons Segment to Dominate the Particle Therapy  Products Market
Figure 22 Multi-Room Systems Segment to Dominate the Particle Therapy Market During the Forecast Period
Figure 23 Pediatric Cancer Segment to Witness Highest Growth in the Particle Therapy Market During the Forecast Period
Figure 24 Treatment Applications to Dominate the Particle Therapy Market During the Forecast Period
Figure 25 Asia Pacific to Register the Highest Growth in the Particle Therapy Market During the Forecast Period
Figure 26 Number of Particle Therapy Facilities Present (As of October 2018) & Under Construction Across the Globe
Figure 27 North America: Particle Therapy Market Snapshot
Figure 28 Europe: Particle Therapy Market Snapshot
Figure 29 Asia Pacific: Particle Therapy Market Snapshot
Figure 30 RoW: Particle Therapy Market Snapshot
Figure 31 Key Developments By Leading Market Players in the Particle Therapy Market, 2015–2018
Figure 32 Particle Therapy Market Share, By Key Player, 2017
Figure 33 Varian Medical Systems, Inc.: Company Snapshot
Figure 34 Ion Beam Applications Sa: Company Snapshot
Figure 35 Sumitomo Heavy Industries: Company Snapshot
Figure 36 Hitachi, Ltd.: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 6747
Published ON
Nov, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Particle Therapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved